It is important to acknowledge that the study, as conducted, does not cover all the aspects of asthma manifestation and it remains to be determined whether the transfer of WT CD4+ T cells is sufficient to reverse AHR and mucus production in PARP-1−/− mice. The gene discussed is AHR; the disease is asthma.